Spinal Elements Announces Appointment of Susan Denman to the Board

Spinal Elements, a spine technology company announced the appointment of Susan Denman to the Company's Board of Directors.

As a highly respected leader in the industry, Ms. Denman brings to the Board extensive experience in advancing the intersection of business and technology to drive growth. Over the course of her career, Ms. Denman has orchestrated transformative strategies for Johnson & Johnson ("J&J"), Sanofi, Nabisco and JPMorgan Chase. She currently serves as Managing Partner of the Susan Denman Group, LLC, which provides board, executive and private equity advisory services and executive coaching, and she is currently a member of the Board of Advisors for Trinity Life Sciences and the Digital Advisory Board for Sage Therapeutics.

"We are excited to welcome Susan to the Spinal Elements Board," said Matt Jennings, Operating Partner of Kohlberg and Chairman of the Board. "Susan is a dynamic, authentic executive who has a demonstrated track record of delivering marketing strategies and technology to consistently drive significant business growth. Her valuable insights and experience will further the Board's diverse skillset and promote Spinal Elements' continued success and value creation."

"I am honored to join the Spinal Elements Board of Directors and to help advance their ability to transform lives through groundbreaking spinal solutions," said Ms. Denman. "With each strategic decision and collaborative endeavor, we will empower patients, inspire our industry and propel Spinal Elements to unparalleled heights, igniting a profound positive change in the world of spinal health."

Ms. Denman holds an MBA from The Wharton School, a bachelor's degree from Duke University and an Executive Certificate from MIT. She was recently honored as one of the Top 50 Most Powerful Women in Tech by the National Diversity Council and Tech Inclusion Council.

Source: Spinal Elements